Yes, that is even funnier. Since NP was such a bad fella and got his ass replaced, that marked the turn around point and smart money started accumulating. So I immediately predicted that we would see the Second Coming of Naddaaaa. Nothing to go on but Naddaaa. There have been a few popcorn farts at taking the pps down but it could not be sustained. I was hoping for more in the thirties but sad that Nadaaa has lost it's punch. Now we have new direction. I doubt there is a buyout. I expect combinations as leronlimab will be ubiquitous for all the indications and it would be really dumb to sell out at even $10. Money has never been a problem. Wouldn't be surprised if Naddaaa is doing a little "consulting" on that. But who really cares about that as it is all behind us with a whole new future with better overall management plus we know so much more about what to expect from a crooked FDA. With the notoriety that leronlimab is getting from the scientific world as each month presses forward, we can only expect good things from now on out. Leronlimab is a world class medicine that will surprise the most doubtful. Just hang on and watch what happens post Aug. Wish I couild get some more in the 30's. Come on shorts where is your action? Give it to me. $CYDY$ Go International Go Samsung Biologics Go Big or Go Home. Yes, I love my weekends as news can come. Next weekend is going to be big, and the following one even bigger. May even put on my pink shorts and hit some golf balls. $$$ CytoDyn $$$ Omite
News 
Market Data 
Discover 
